SOW
DNTH icon

State of Wyoming’s Dianthus Therapeutics DNTH Stock Holding History

State of Wyoming’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
+3,080
New +$269K 0.03% 702
2022
Q2 		– Sell
-96
Closed -$4K – 1937
2022
Q1 		$4K Buy
96
+2
+2% +$109 ﹤0.01% 1670
2021
Q4 		$7K Buy
94
+4
+4% +$402 ﹤0.01% 1694
2021
Q3 		$10K Buy
90
+17
+23% +$1.98K 0.01% 1025
2021
Q2 		$11K Buy
+73
New +$13.4K 0.01% 1001

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

State of Wyoming's DNTH Position: Q2 2026 in Review

State of Wyoming opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 3,080 shares worth $300K. The stake represents 0.03% of the portfolio and ranks #702 among its holdings. This is a return to the name: State of Wyoming previously reported a position in DNTH as recently as Q1 2022.

State of Wyoming first reported a position in DNTH in Q2 2021 and has held it in 5 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • State of Wyoming held 3,080 shares of Dianthus Therapeutics worth $300K as of Q2 2026.
  • Dianthus Therapeutics was a new State of Wyoming position in Q2 2026.
  • Dianthus Therapeutics made up 0.03% of State of Wyoming's portfolio in Q2 2026, its #702 holding.
  • State of Wyoming first reported a position in Dianthus Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.